Lauren Lieberman
Barclays Bank PLC, Research Division

Good afternoon, everyone, and thank you for joining us. I'm pleased to welcome you to a fireside chat with Kimberly-Clark today. The company is in the midst of a strategic evolution, a significant one, reorienting the portfolio by reducing its international consumer tissue exposure through a joint venture with Suzano while expanding into consumer health with the proposed acquisition of Kenvue, which will create a broader platform across personal care and consumer health. To discuss the strategy, the rationale behind these moves and how management is thinking about execution and value creation from here, I'm joined by Mike Hsu, the company's Chairman and Chief Executive Officer; Nelson Urdaneta, the company's Chief Financial Officer; and Chris Jakubik, Head of Investor Relations. So thank you all for being here. Thanks so much for making the trip to London.

Michael Hsu
Chairman & CEO

Great to be here, Lauren.

Nelson Urdaneta
Senior VP & CFO

Thank you.

Lauren Lieberman
Barclays Bank PLC, Research Division

So we'll get started. So first thought was that given many investors here today have a somewhat outdated perspective of the company, I wanted to start off at a high level. So over 2 years -- just about over 2 years ago, you announced the Powering Care strategy. Mike, could you start by giving an overview of that strategy and perhaps where it suggests the greatest change from how the company was operating previously.

Michael Hsu
Chairman & CEO

Okay. Yes. Thank you, Lauren. Yes, I think the core idea of Powering Care is the